Alan Daugherty

Oct. 19: Cardiovascular research

Delaware Cardiovascular Research Center sets second annual symposium


3:44 p.m., Sept. 6, 2012--The Delaware Cardiovascular Research Center (DCRC) will hold its second annual symposium from 8 a.m. to 5 p.m., Friday, Oct. 19, at the Embassy Suites Hotel, 654 South College Avenue, in Newark.

The symposium will bring together cardiovascular researchers from tri-state area institutions to share recent advances in the field and to facilitate productive collaborations through idea sharing and the development of an infrastructure for cardiovascular disease education and research. 

Research Stories

GoBabyGo talk

UD's Cole Galloway joined 75 other internationally recognized thought leaders at TEDMED 2014, "Unlocking Imagination in Service of Health and Medicine," to share the story of the GoBabyGo Program.

Self-assembled materials, InSPACE

A University of Delaware engineer is working to create new "smart materials" through the NASA InSPACE program.

The morning keynote speaker is Alan Daugherty of the University of Kentucky (UK), who will speak about the role of angiotensin peptides in the development of atherosclerosis and aortic aneurysms. 

Daugherty is the director of the Cardiovascular Research Center at UK and is the editor-in-chief of Atherosclerosis, Thrombosis and Vascular Biology, the official journal of the American Heart Association. 

The afternoon session welcomes keynote speaker Tatiana Byzova, the Robert Canova Endowed Chair in Angiogenesis Research in the Department of Molecular Cardiology, Center for Thrombosis and Vascular Biology at the
Lerner Research Institute, Cleveland Clinic Foundation.

Byzova will speak about the mechanisms governing the pathological and adaptive vasculature development and neoangiogenesis in adult organisms. 

There will also be presentations by invited faculty from the University of Delaware, Temple University, the University of Pennsylvania, Thomas Jefferson University, and guest speakers from the National Institutes of Health Chemical Genomics Center (NCGC), Nemours, Merck Pharmaceuticals and Perkin Elmer.

Presentations will be on basic and translational cardiovascular research as well as molecular mechanism of thrombosis, anti-thrombotic interventions, and assay development for high throughput screening for intervention of various cardiovascular diseases.

In addition, there will be a poster session featuring work by UD scientists, graduate students, and outside presenters. Several awards for the outstanding posters will be presented. Posters should be no larger than 32 by 40 inches. Vendors will also be on-site.

The symposium is free and a continental breakfast and lunch will be provided, however registration is required. Registration is available on the DCRC website.

icon-fb icon-tw icon-yt icon-fs

News Media Contact

University of Delaware
Communications and Public Affairs

UDaily is produced by
Communications and Public Affairs

The Academy Building
105 East Main Street
University of Delaware
Newark, DE 19716 | USA
Phone: (302) 831-2792
University of Delaware • Newark, DE 19716 • (302) 831-2792 • ©2012
University of Delaware • Newark, DE 19716 • USA • Phone: (302) 831-2792 • © 2013
Comments|Contact Us|Legal Notices